Brief: Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare Conference
12/01/2026 12:42
Jan 12 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O: ULTRAGENYX PROVIDES FINANCIAL AND BUSINESS UPDATES AT J.P. MORGAN ANNUAL HEALTHCARE CONFERENCE 2025 REVENUE EXCEEDS GUIDANCE AT $672 MILLION-$674 MILLION CASH AND INVESTMENTS ABOUT $735 MILLION AS OF DEC 31, 2025 FY2025 REVENUE VIEW $655.6 MILLION -- LSEG IBES DATA Source text: ID:nGNX3xlWJW Further company coverage: RARE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ultragenyx Pharmaceutical
See all newsBrief: Ultragenyx Pharmaceutical Enters Settlement Agreement With Navinta On Dojolvi Patent Litigation - SEC Filing
Ultragenyx gains on $210 million US FDA voucher sale
Brief: Ultragenyx Pharmaceutical - Under Deal With U.S. Department Of Health Co To Pay 20% Of Prv Sale Proceeds To Nih
Brief: Ultragenyx Enters Into Agreement To Sell Rare Pediatric Disease Priority Review Voucher For $210 Million
U.S. STOCKS ON THE MOVE-CoreWeave, StubHub, Ultragenyx